Miris AB announces the signing of a new distribution agreement with Almazar Medical Corp. The agreement strengthens Miris' commitment to improving neonatal nutrition globally and represents a significant expansion of the company's presence in one of the world's fastest-growing healthcare markets. The total medical technology market in the Middle East is valued at approximately 11 billion USD.

"The collaboration with Almazar Medical Corp marks an important milestone in our mission to make individualized fortification accessible worldwide," says Camilla Sandberg, CEO of Miris AB. "Their strong regional presence, technical expertise, and deep relationships within neonatal care in the region are major assets as Miris now enters one of the fastest-growing markets for medical technology."

"We are confident that this partnership will enable us to deliver greater value, expand our market reach, and meet our customers' growing needs with excellence and reliability. We look forward to a successful journey together," says Zaid Hasan, Executive Director, Almazar Medical Corp.

The agreement reflects Miris' continued commitment to expanding access to individualized fortification for preterm infants globally.

Visit Miris webpage at: www.mirissolutions.com